Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pituitary tumour benign
ADR ID BADD_A05942
ADR Hierarchy
05      Endocrine disorders
05.03      Hypothalamus and pituitary gland disorders
05.03.05      Pituitary neoplasms
05.03.05.003      Pituitary tumour benign
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.37      Endocrine neoplasms benign
16.37.02      Endocrine neoplasms benign NEC
16.37.02.001      Pituitary tumour benign
Description Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. [MeSH]
MedDRA Code 10061538
MeSH ID D010911
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign neoplasm of pituitary gland and craniopharyngeal duct | Benign neoplasm of pituitary gland and craniopharyngeal duct (pouch) | Pituitary adenoma | Pituitary macroadenoma | Pituitary microadenoma | Pituitary neoplasm benign | Pituitary tumor benign | Pituitary tumour benign NOS | Pituitary neoplasm benign recurrent | Pituitary tumour benign | Pituitary Neoplasms | Neoplasm, Pituitary | Neoplasms, Pituitary | Pituitary Neoplasm | Pituitary Tumors | Pituitary Tumor | Tumor, Pituitary | Tumors, Pituitary | Pituitary Adenoma | Adenoma, Pituitary | Adenomas, Pituitary | Pituitary Adenomas | Pituitary Carcinoma | Carcinoma, Pituitary | Carcinomas, Pituitary | Pituitary Carcinomas | Cancer of the Pituitary | Pituitary Cancer | Cancer, Pituitary | Cancers, Pituitary | Cancer of Pituitary | Pituitary Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00315Buserelin acetate--
BADD_D00490Clobetasol propionate0.001867%
BADD_D00511Clozapine0.001223%
BADD_D00680Dimethyl fumarate0.000600%
BADD_D00898Finasteride0.000189%
BADD_D00932Fluoxetine0.000020%
BADD_D01038Goserelin0.000501%
BADD_D01073Histrelin--
BADD_D01074Histrelin acetate--
BADD_D01257Letrozole0.000263%
BADD_D01260Leuprolide acetate--
BADD_D01281Levonorgestrel0.000709%
BADD_D01285Levothyroxine0.000010%
BADD_D01401Metformin0.000008%
BADD_D01513Nafarelin--
BADD_D01656Paliperidone0.010791%
BADD_D01684Pasireotide0.000186%
BADD_D01834Prednisone0.000013%
BADD_D01951Risperidone0.000606%
BADD_D01954Rivaroxaban0.000063%
BADD_D02026Simvastatin0.000011%
BADD_D02047Sodium oxybate0.000724%
BADD_D02174Testosterone undecanoate-
BADD_D02297Triptorelin--
BADD_D02412Octreotide0.000186%
BADD_D02464Fingolimod0.000892%
The 1th Page    1    Total 1 Pages